Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Rogatsch, M; Schmid, J; Lax, S; Uranitsch, M; Schmid-Zalaudek, K; Giuffrida, R; Zalaudek, I.
Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab.
Eur J Cancer. 2018; 90:146-148
Doi: 10.1016/j.ejca.2017.11.008
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Zalaudek Iris
- Co-Autor*innen der Med Uni Graz
-
Schmid Johannes
-
Schmid-Zalaudek Karin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Adenocarcinoma - drug therapy
-
Adenocarcinoma - pathology
-
Aged, 80 and over -
-
Antibodies, Monoclonal, Humanized - therapeutic use
-
Antineoplastic Agents, Immunological - therapeutic use
-
Apocrine Glands - pathology
-
Humans -
-
Male -
-
Programmed Cell Death 1 Receptor - antagonists & inhibitors
-
Sweat Gland Neoplasms - drug therapy
-
Sweat Gland Neoplasms - pathology